Discover 250 paid clinical trials in Spokane, Washington. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 250
A Study of Buntanetap in Participants With PD
for
Parkinson's Disease (PD), Deep Brain Stimulation
Location: Spokane WA, Englewood CO, Fountain Valley CA,
Sponsor: Annovis Bio Inc.
Sex: All
Age: 40 - 70+
Code: NCT07284784
Phase 2, Phase 3, Recruiting
Study of AGN-151607-DP to Assess Adverse Events and Change in Disease Activity in Adult Participants With Upper Limb Essential Tremor
for
Upper Limb Essential Tremor
Location: Spokane WA, Fresno CA, Fullerton CA, Carlsbad CA,
Sponsor: AbbVie
Sex: All
Age: 18 - 70+
Code: NCT07673107
Phase 2, Recruiting
Low-dose Carbon Monoxide (HBI-002) Trial to Evaluate Safety, Tolerability, PK, and Biomarkers in Parkinson's Disease
for
Parkinson Disease
Location: Spokane WA, Fountain Valley CA, Farmington Hills MI,
Sponsor: Hillhurst Biopharmaceuticals, Inc.
Sex: All
Age: 40 - 70+
Code: NCT07005180
Phase 2, Recruiting
A Study of Bispecific Antibody MCLA-158 in Patients With Advanced Solid Tumors
Location: Spokane WA, Salt Lake City UT, Lone Tree CO,
Sponsor: Genmab
Sex: All
Age: 18+
Code: NCT03526835
Phase 1, Phase 2, Recruiting
A Study to Evaluate LY3537021 for the Treatment of Nausea and Vomiting Caused by Chemotherapy in Adults With Cancer
for
Nausea, Vomiting,
Location: Spokane WA, Medford OR, Ogden UT, Walnut Creek CA,
Sponsor: Eli Lilly and Company
Sex: All
Age: 18+
Code: NCT07169851
Phase 2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Family Communications After Genetic Testing
for
Colon Adenocarcinoma, Colorectal Adenocarcinoma,
Location: Spokane WA, Post Falls ID, Coeur d'Alene ID,
Sponsor: Alliance for Clinical Trials in Oncology
Sex: All
Age: 18+
Code: NCT07143487
Recruiting
Testing Whether High Dose Chemotherapy and Infusion of the Patients' Own Stem Cells Improves Survival in Patients With Peripheral T-cell Lymphoma Who Achieved a Complete Response at the End of the Initial Chemotherapy